It may be significant that the one double-blind comparative study ( Qunibi et al. 2004 ) reported no statistically significant difference between sevelamer and calcium acetate in subjective symptom scores for gastrointestinal adverse events, although the study was not powered to detect a difference.
← all excerpts
Sevelamer as a phosphate binder in adult hemodialysis patients: an evidence-based review of its therapeutic value.
1
—
—